Design and evaluation of a liposomal delivery system targeting the posterior segment of the eye

Journal of Controlled Release

Volumn 136, Issue 3, 2009, Pages 247-253

  Hironaka, Kohei ^a   Inokuchi, Yuta ^a   Tozuka, Yuichi ^a   Shimazawa, Masamitsu ^a   Hara, Hideaki ^a   Takeuchi, Hirofumi ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Atomic force microscopy; Eyedrops; Liposomes; Posterior segment of the eye; Retina

Indexed keywords

COUMARIN 6; EYEDROPS; FLUORESCENCE EMISSION; LIPOSOMAL DELIVERY SYSTEM; LIPOSOMAL SUSPENSION; MULTI-LAMELLAR VESICLES; PHOSPHATIDYLCHOLINE; POSTERIOR SEGMENT; POSTERIOR SEGMENT OF THE EYE; RETINA; SUBMICRON-SIZED;

ATOMIC FORCE MICROSCOPY; ATOMS; DIMETHYL SULFOXIDE; LIPOSOMES; PHOSPHOLIPIDS;

FLUORESCENCE;

COUMARIN 6; COUMARIN DERIVATIVE; DIMETHYL SULFOXIDE; DISTEAROYLPHOSPHATIDYLCHOLINE; EYE DROPS; LIPOSOME; PHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; ATOMIC FORCE MICROSCOPY; CONJUNCTIVA; CONTROLLED STUDY; CORNEA CELL; CYTOTOXICITY; DRUG DESIGN; DRUG TARGETING; EYE; EYE POSTERIOR POLE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; IMAGE ANALYSIS; LIPOSOMAL DELIVERY; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RETINA; RIGIDITY;

ANIMALS; CELL LINE; CELL SURVIVAL; CHICKENS; CONJUNCTIVA; CORNEA; COUMARINS; EYE; FLUORESCENT DYES; HUMANS; LIPOSOMES; MALE; MICE; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, FLUORESCENCE; OPHTHALMIC SOLUTIONS; OVUM; PARTICLE SIZE; PHOSPHATIDYLCHOLINES; RETINA; THIAZOLES;

EID: 65749105937     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2009.02.020     Document Type: Article

References (31)

1. Colucciello M. Intravitreal bevacizumab and triamcinolone acetonide combination therapy for exudative neovascular age-related macular degeneration: short-term optical coherence tomography results. J. Ocul. Pharmacol. Ther. 24 1 (2008) 15-24
2. Fattal E., and Bochot A. Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA. Adv. Drug Deliv. Rev. 58 11 (2006) 1203-1223
3. Yasukawa T., Kimura H., Tabata Y., and Ogura Y. Biodegradable scleral plugs for vitreoretinal drug delivery. Adv. Drug Deliv. Rev. 52 1 (2001) 25-36
4. Duvvuri S., Majumdar S., and Mitra A.K. Drug delivery to the retina: challenges and opportunities. Expert Opin. Biol. Ther. 3 1 (2003) 45-56
5. Sahoo S.K., Dilnawaz F., and Krishnakumar S. Nanotechnology in ocular drug delivery. Drug Discov. Today 13 3-4 (2008) 144-151
6. Takeuchi H., Matsui Y., Sugihara H., Yamamoto H., and Kawashima Y. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. Int. J. Pharm. 303 1-2 (2005) 160-170
7. Kaur I.P., Garg A., Singla A.K., and Aggarwal D. Vesicular systems in ocular drug delivery: an overview. Int. J. Pharm. 269 1 (2004) 1-14
8. Hathout R.M., Mansour S., Mortada N.D., and Guinedi A.S. Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS Pharm. Sci. Tech. 8 1 (2007) 1
9. Shen Y., and Tu J. Preparation and ocular pharmacokinetics of ganciclovir liposomes. Aaps J. 9 3 (2007) E371-377
10. Thomson N.H., Collin I., Davies M.C., Palin K., Parkins D., Roberts C.J., Tendler S.J.B., and Williams P.M. Atomic force microscopy of cationic liposomes. Langmuir 16 11 (2000) 4813-4818
11. Araki-Sasaki K., Ohashi Y., Sasabe T., Hayashi K., Watanabe H., Tano Y., and Handa H. An SV40-immortalized human corneal epithelial cell line and its characterization. Invest. Ophthalmol. Vis. Sci. 36 3 (1995) 614-621
12. Shimazawa M., Inokuchi Y., Ito Y., Murata H., Aihara M., Miura M., Araie M., and Hara H. Involvement of ER stress in retinal cell death. Mol. Vis. 13 (2007) 578-587
13. Ramirez-Aguilar K.A., and Rowlen K.L. Tip characterization from AFM images of nanometric spherical particles. Langmuir 14 9 (1998) 2562-2566
14. Nakano K., Tozuka Y., Yamamoto H., Kawashima Y., and Takeuchi H. A novel method for measuring rigidity of submicron-size liposomes with atomic force microscopy. Int. J. Pharm. 355 1-2 (2008) 203-209
15. Taylor K.M.G., and Morris R.M. Thermal analysis of phase transition behaviour in liposomes. Thermochim. Acta 248 2 (1995) 289-301
16. Taniguchi K., Yamamoto Y., Itakura K., Miichi H., and Hayashi S. Assessment of ocular irritability of liposome preparations. J. Pharmacobiodyn. 11 9 (1988) 607-611
17. De Saint Jean M., Debbasch C., Brignole F., Rat P., Warnet J.M., and Baudouin C. Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells. Curr. Eye Res. 20 2 (2000) 85-94
18. Mainardes R.M., Urban M.C., Cinto P.O., Khalil N.M., Chaud M.V., Evangelista R.C., and Gremiao M.P. Colloidal carriers for ophthalmic drug delivery. Curr. Drug Targets 6 3 (2005) 363-371
19. Takeuchi H., Yamamoto H., and Kawashima Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv. Drug Deliv. Rev. 47 1 (2001) 39-54
20. Yoncheva K., Lizarraga E., and Irache J.M. Pegylated nanoparticles based on poly(methyl vinyl ether-co-maleic anhydride): preparation and evaluation of their bioadhesive properties. Eur. J. Pharm. Sci. 24 5 (2005) 411-419
21. Kassem M.A., Abdel Rahman A.A., Ghorab M.M., Ahmed M.B., and Khalil R.M. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. Int. J. Pharm. 340 1-2 (2007) 126-133
22. Amrite A.C., Edelhauser H.F., and Kompella U.B. Modeling of corneal and retinal pharmacokinetics after periocular drug administration. Invest. Ophthalmol. Vis. Sci. 49 1 (2008) 320-332
23. Amrite A.C., Edelhauser H.F., Singh S.R., and Kompella U.B. Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration. Mol. Vis. 14 (2008) 150-160
24. Amrite A.C., and Kompella U.B. Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration. J. Pharm. Pharmacol. 57 12 (2005) 1555-1563
25. Muramatsu K., Maitani Y., and Nagai T. Dipalmitoylphosphatidylcholine liposomes with soybean-derived sterols and cholesterol as a carrier for the oral administration of insulin in rats. Biol. Pharm. Bull. 19 8 (1996) 1055-1058
26. Muramatsu K., Maitani Y., Takayama K., and Nagai T. The relationship between the rigidity of the liposomal membrane and the absorption of insulin after nasal administration of liposomes modified with an enhancer containing insulin in rabbits. Drug. Dev. Ind. Pharm. 25 10 (1999) 1099-1105
27. Sasaki H., Yamamura K., Nishida K., Nakamura J., and Ichikawa M. Delivery of drugs to the eye by topical application. Prog. Retin. Eye Res. 15 2 (1996) 583-620
28. Hughes P.M., Olejnik O., Chang-Lin J.E., and Wilson C.G. Topical and systemic drug delivery to the posterior segments. Adv. Drug Deliv. Rev. 57 14 (2005) 2010-2032
29. Huang H.S., Schoenwald R.D., and Lach J.L. Corneal penetration behavior of β-blocking agents II: assessment of barrier contributions. J. Pharm. Sci. 72 11 (1983) 1272-1279
30. Hamalainen K.M., Kananen K., Auriola S., Kontturi K., and Urtti A. Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera. Invest. Ophthalmol. Vis. Sci. 38 3 (1997) 627-634
31. Koevary S.B. Pharmacokinetics of topical ocular drug delivery: potential uses for the treatment of diseases of the posterior segment and beyond. Curr. Drug Metab. 4 3 (2003) 213-222